Anlotinib monotherapy in recurrent or metastatic nasopharyngeal carcinoma: a multicenter case-series analysis
Anlotinib monotherapy demonstrated positive efficacy in patients with rmNPC. It was well tolerated by these patients and had acceptable toxicity.
Authors
- Yuan Xie (ORCID: https://orcid.org/0000-0003-0569-1253)
- Yuhuai Xie (ORCID: https://orcid.org/0000-0001-7280-7098)
- Kequan Chen (ORCID: https://orcid.org/0000-0001-8432-7032)
- Yixin Su
- Yunyan Mo
- Yufei Pan (ORCID: https://orcid.org/0000-0001-9848-6106)
- Xiangyun Kong (ORCID: https://orcid.org/0009-0008-3031-2386)
- Guanjie Qin (ORCID: https://orcid.org/0000-0002-5103-3641)
- Bin Zhang (ORCID: https://orcid.org/0000-0002-6286-6227)
- Jiän Zhang (ORCID: https://orcid.org/0000-0002-0557-886X)
- Wei Jiang (ORCID: https://orcid.org/0000-0002-8467-5042)
- Yong Liang
- Ruibin Zhang (ORCID: https://orcid.org/0000-0002-8535-358X)
- Fengfei Qin
- Xiaolan Ruan (ORCID: https://orcid.org/0000-0002-8650-4917)
- Huiyun Yang
- Jianxun Lu
- Jinxuan Dai
Institutions
- Guilin Medical University (CN)
- People's Hospital of Bishan District (CN)
- 181st Hospital of Chinese People's Liberation Army (CN)
- Kaiping Central Hospital (CN)
- First People's Hospital of Nanning (CN)
- Nanxi Mountain Hospital (CN)
- Second People’s Hospital of Yibin (CN)
- Wuzhou Red Cross Hospital (CN)
Publication Details
- Journal
- Radiology and Oncology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2478/raon-2025-0059
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00